Matzke G R, O'Connell M B, Collins A J, Keshaviah P R
Clin Pharmacol Ther. 1986 Oct;40(4):425-30. doi: 10.1038/clpt.1986.201.
The disposition of vancomycin was assessed in five patients receiving hemofiltration after intravenous dosing with an 18 mg/kg dose after a hemofiltration procedure. The serum concentration-time profile was characterized before, during, and after the next hemofiltration procedure. The t 1/2 of vancomycin was 136.0 +/- 27.2 hours (mean +/- SD) before hemofiltration and 4.1 +/- 1.2 during hemofiltration. Approximately 400 mg of vancomycin was recovered in the filtrate and the hemofiltration clearance was 152.6 +/- 21.5 ml/min. A significant relationship was observed between vancomycin clearance and ultrafiltration flow rate (r = 0.9914). A marked rebound in vancomycin serum concentration (52.4% +/- 15.6%) was observed in all patients. Hemofiltration has a significant effect on the disposition of vancomycin. Because of the marked interpatient variability in elimination t 1/2 and the degree and time course of the rebound, an individualized approach to vancomycin therapy in this patient population is recommended.
在5例接受血液滤过的患者中,于血液滤过术后静脉给予18mg/kg剂量的万古霉素,评估其处置情况。在下一次血液滤过术前、术中和术后对血清浓度-时间曲线进行了表征。血液滤过前万古霉素的t1/2为136.0±27.2小时(均值±标准差),血液滤过期间为4.1±1.2小时。滤液中回收了约400mg万古霉素,血液滤过清除率为152.6±21.5ml/min。观察到万古霉素清除率与超滤流速之间存在显著相关性(r = 0.9914)。所有患者均观察到万古霉素血清浓度显著反弹(52.4%±15.6%)。血液滤过对万古霉素的处置有显著影响。由于消除t1/2以及反弹程度和时间过程存在显著的患者间变异性,建议对该患者群体采用个体化的万古霉素治疗方法。